CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers

Event Focused on Ensuring Patient Safety is Top Priority of Follow-on Biologic Legislation Being Debated on Capitol Hill WASHINGTON, July 14 /PRNewswire-USNewswire/ -- Tomorrow, Wednesday, July 15th, on Capitol Hill, the Center for Medicine in the Public Interest will host a brie...

CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- Next Wednesday, July 15th, on Capitol Hill, the Center for Medicine in the Public Interest will host a briefing followed by a question-and-answer session for media and Congressional Staff entitled: "A Follow-On Biologics Legislation Update; Congression...

New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimer's Disease Market

Sales of Acetylcholinesterase Inhibitors, Which Currently Dominate the Market, Will Decline by $1 Billion from 2008 to 2018, According to a New Report from Decision Resources WALTHAM, Mass., June 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for...

GPhA Statement on FTC Report on 'Follow-on Biologic Drug Competition'

ARLINGTON, Va., June 10 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger regarding publication of the Federal Trade Commission (FTC) Report on "Follow-on Biologic Drug Competition." "Today's repor...

FDA Extends Review Timeline for STELARA(TM) (ustekinumab) Biologic License Application by Three Months

HORSHAM, Pa., May 26 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today that the U.S. Food and Drug Administration (FDA) has extended by three months the review timeline for the Biologic License Application (BLA) for STELARA(TM) (ustekinumab) to provide time for a full review of an amendm...

Medical Community Reacts to Obama and Congressional Plans to Approve Generic Forms of Biologic Medicines

National Press Club Event to Highlight Patient Safety and Discuss Policy Recommendations for Moving Forward WASHINGTON, April 16 /PRNewswire-USNewswire/ -- The Obama administration's goal of expanding the availability of generic forms of biologic drugs - and a variety of congressional effor...

More>>

BioLogic in Medical Technology

VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE

BEDFORD, Mass., July 30 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today that scientists reporting in the July 31 issue of SCIENCE have discovered a key disease-related biologic pathway using an integrated and ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

SOUTH SAN FRANCISCO, Calif., July 23 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that in the TASKi3 Phase 2b clinical trial in rheumatoid arthritis (RA) patients who had failed to respond to at least one biologic treatment, the group treat...

Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

SAN DIEGO, Dec. 8 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that Roche has dosed the first patient in a Phase 1 pharmacokinetic clinical trial with...

Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)

Company's INS-20 Receives Regulatory Clearance to Begin Phase I Clinical Trial RICHMOND, Va., Oct. 14 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that it has received approval from the United Kingdom's Medic...

Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company

Company Intends to Request Meeting with FDA Regarding Possible Phase III Trial Based on Human Data Demonstrating Bioequivalence of INS-19 to Neupogen(R) RICHMOND, Va., July 10, 2008 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a developer of follow-on b...

Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)

INS-19 Receives Regulatory Clearance RICHMOND, Va., April 16 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced that it has received approval from the United Kingdom's Medicines and Healthcare produ...

BioLogic in Medical Products

Bard AlloMax Surgical Graft

Description:... Bard AlloMax Surgical Graft is an all-natural biologic implant derived from human dermal collagen. It is prepared using the proven Tutoplast process with over 30 yrs experience to remove all non-collageno...
Company:Davol, Inc.

BioArc™ TO Subfascial Hammock

Description:...n innovative hybrid system combining synthetic and biologic materials. It is the only hybrid sling currently a...c utilizes a polypropylene mesh for fixation and a biologic for the suburethral support. Tensioning and loosen...ative tensioning refinement without distorting the biologic graft material. Suburethral...
Company:AMS

BioArc™ SP Sling System

Description:...n innovative hybrid system combining synthetic and biologic materials. It is the only hybrid sling currently a...c utilizes a polypropylene mesh for fixation and a biologic for the suburethral support. Tensioning and loosen...ative tensioning refinement without distorting the biologic graft material. Suburethral...
Company:AMS

In-Fast™ Ultra Transvaginal Sling

Description:...to drive two small titanium bone screws into the posterior aspect of the pubic bone. Each screw has a suture attached that facilitates attachment to a biologic graft or synthetic mesh that is placed under the urethra, thus restoring lost pubocervical support. The graft or mesh provides support for the urethra...
Company:AMS

Erythropoietin (EPO) ELISA

Description:...itro diagnostic use, as an aid in the diagnosis of anemias and polycythemias. With the advent of the administration of recombinant erythropoietin as a biologic therapy to increase red blood cell mass, an erythropoietin assay may be used also to aid in the prediction and monitoring of response to recombinant e...
Company:MD Biosciences

ACT PLUS Automated Coagulation Timer System

Description:...are performed. The ability to externally transfer or save data to a floppy disk enhances the systems versatility. Manufactured by the Medtronic biologic Therapeutics and Diagnostics business, the ACT Plus System combines a trusted standard in precise clot detection technology with state-of-the-art user...
Company:Medtronic Inc.

BioLogic in Biological News

Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck

WHITEHOUSE STATION N.J., PRINCETON, N.J. and JAMAICA PLAIN, Mass., April 21, 2009 Merck & Co., Inc., (through an affiliate), Medarex, Inc. (NASDAQ: MEDX) and Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that they have signed an...

New orthopaedic society launched to promote research, use of biologic treatments

LAS VEGAS February 25, 2009 The first international society dedicated to the evaluation and use of new biologic treatments for orthopaedic conditions has been formed. The Biologic Orthopaedic Society (BOS; www.BiologicOrtho.com ) held its inaugural meeting Tuesday, February 24, 2009 at the V...

NIST trumps the clumps: Making biologic drugs safer

Scientists at the National Institute of Standards and Technology (NIST) have developed a technique to measure the formation of clumps of proteins in protein-based pharmaceuticals. This first systematic study* clarifies the conditions under which scientists can be assured that their instruments are...

New biologic treatment for tennis elbow may replace surgery for chronic sufferers

A person suffering from tennis elbow may not have to look any further than his or her own body for the most effective treatment, according to a study published in the November issue of The American Journal of Sports Medicine. Specially-prepared platelets taken from the patient which are then re-i...

Newly discovered gene fusion may lead to improved prostate cancer diagnosis

...h genetic rearrangements. This fusion and protein are only found in cancer cells, and not within normal cells. Ongoing work is exploring the potential biologic implications of this discovery. However, the diagnostic implications are more immediate because these types of genetic chimera occur only in cancer. ...

2 reproductive factors are important predictors of death from ovarian cancer

...lations, specifically among older women and those of various ethnicities, according to Robbins. Additionally, she suggested that studies examining the biologic properties of ovarian tumors among women with high lifetime ovulatory cycles may help to explain the relationship between number of ovulatory cycles a...

More>>

BioLogic in Biological Technology

China Biologic Products Hosts its First Forum for Strategy and Development

TAIAN CITY, China, July 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company hosted a ...

China Biologic Products Closes the $9.6 Million Private Placement

TAI'AN CITY, China, June 11 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on June 10, 2009, th...

China Biologic Products Enters Into Private Placement Agreements to Raise $9.6 Million

TAIAN CITY, China, June 8 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company has entere...

SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models

CALGARY, May 19 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today reported encouraging data from the Company's Apo AI(Milano) development program. Results from recent preclinical studies show that SemBi...

China Biologic Products Announces Strong First Quarter 2009 Results

TAI'AN, Shandong, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), reported strong financial results for the f...

China Biologic Products Announces 2009 First Quarter Results Conference Call

TAI'AN CITY, Shandong, China, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will host a confer...

More>>

BioLogic in Biological Products

Standard BioLogic LP System, 220-240 V from Bio-Rad

Description: The standard BioLogic LP system, 220-240 V, is used for low-pressure chromatography applications without fraction collection. The system includes the BioLogic LP controller, BioLogic rack, accessory kit with MV-6 injection valve, proportioning valve or mixer, UV optics, conductivity cell, tubing an...
Company:Bio-Rad

Vi-CELL Cell Viability Analyzer from Beckman Coulter

Description:... Todays research and biologic production demands on cell and tissue culture assumes no guesswork to confirming viable cell populations. Therefore, both cell concentration and perce...
Company:Beckman Coulter

Piston Kit, for F10 pump from Bio-Rad

Description:... The piston kit includes 2 pistons to service one F10 pump of a biologic DuoFlow workstation....
Company:Bio-Rad

F40 Piston Assembly from Bio-Rad

Description:... The F40 piston assembly is supplied as two assemblies to service one F40 pump of a biologic DuoFlow workstation....
Company:Bio-Rad

F40 Pump Maintenance Kit from Bio-Rad

Description:... The F40 pump maintenance kit is used to service one F40 pump of a biologic DuoFlow workstation. It includes 2 piston seals, 4 check valves, seal removal tool, and 2 O-rings....
Company:Bio-Rad

SVT3-2 Diverter Valve from Bio-Rad

Description:... The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the biologic DuoFlow system....
Company:Bio-Rad

More>>

BioLogic in Biological Dictionary

SCAR

... Scars are areas of fibrous tissue that replace normal skin after injury. A scar results from the biologic process of wound repair in the skin and other tissues of the body. Thus, scarring is a natural part of the healing... The American Academy of Derma...

Biologics

...d by living cells derived from human, plant, animal, or microorganism. biologic Biologics include a wide range of medicinal products such as vaccines , b...elings Website: Http://Www.Bielings.Com Biologics (BRMs, TNF Blockers, biologic DMARDs) drug information, dosage, side ... Do Biologics Prevent Joint Dam...